Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: results of a phase I trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples